Champions Oncology (CSBR) Accumulated Expenses (2011 - 2026)

Champions Oncology's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 47.6% year-over-year to $3.3 million; the TTM figure through Jan 2026 stood at $3.3 million (up 47.6% YoY), while the FY2025 annual figure was $2.6 million, up 18.33% from the prior year.
• Accumulated Expenses was $3.3 million for Q1 2026 at Champions Oncology, up from $2.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q1 2026 to a low of $1.7 million in Q4 2022.
• Historically, Accumulated Expenses has averaged $2.2 million across 5 years, with a median of $2.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses slipped 14.12% in 2025, then soared 47.6% in 2026.
• A 5-year view of Accumulated Expenses shows it stood at $1.7 million in 2022, then gained by 21.14% to $2.0 million in 2023, then advanced by 10.48% to $2.2 million in 2024, then slipped by 2.1% to $2.2 million in 2025, then surged by 52.93% to $3.3 million in 2026.
• The last three Accumulated Expenses figures came in at $3.3 million (Q1 2026), $2.2 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.